Tobias Financial Advisors, Inc. Anavex Life Sciences Corp. Transaction History
Tobias Financial Advisors, Inc.
- $483 Million
- Q4 2024
Shares
2 transactions
Others Institutions Holding AVXL
# of Institutions
189Shares Held
29.2MCall Options Held
894KPut Options Held
821K-
Black Rock Inc. New York, NY6.39MShares$57.2 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.68MShares$41.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.41MShares$21.6 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.87MShares$16.8 Million0.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA1.13MShares$10.2 Million0.0% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $698M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...